or Try an Advanced Search...

    Fungal Infection Stocks List

    Symbol Grade Name % Change
    SCYX F SCYNEXIS, Inc. -3.23
    GILD F Gilead Sciences, Inc. 0.07
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Fungal Infections Medicine Angina Anti Infectives Antibiotics Biopharmaceutical Cardiovascular Disease Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis Disease Dog Drugs Dry Eye Disease Eye Eye Diseases Gilead Sciences HIV Hepatitis C

    Related ETFs - A few ETFs which own one or more of the above listed Fungal Infection stocks.

    Symbol Grade Name Weight
    IBB D iShares Nasdaq Biotechnology Index Fund 8.16
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.13
    BBH D Market Vectors Biotech ETF 7.99
    BIS B ProShares UltraShort Nasdaq Biotechnology 7.41
    BIB D ProShares Ultra Nasdaq Biotechnology 6.01
    View all Fungal Infection ETFs...
    Compare ETFs
    Compare IBB to BIB Compare IBB to IBBQ Compare IBBQ to BIS

        Fungal Infection Stocks Recent News

        Date Stock Title
        Apr 23 GILD Incyte (INCY) Earnings Expected to Grow: Should You Buy?
        Apr 23 GILD Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?
        Apr 22 GILD Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
        Apr 22 GILD Gilead Sciences: Some Signs Of An Impending Bottom
        Apr 22 GILD Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
        Apr 21 GILD Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
        Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
        Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
        Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
        Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
        Apr 18 GILD Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Fungal Infections Medicine Angina Anti Infectives Antibiotics Biopharmaceutical Cardiovascular Disease Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis Disease Dog Drugs Dry Eye Disease Eye Eye Diseases Gilead Sciences HIV Hepatitis C
        Fungal Infection

        Fungal infections are caused by microscopic fungi that live on the skin, hair, and nails. They can cause a variety of symptoms, including itching, redness, and scaling. Fungal infections can be treated with antifungal medications, such as creams, ointments, and pills.

        Browse All Tags